腸癌(Intestinal Cancer):世界の治験レビュー(2015年上半期版)

【英語タイトル】Intestinal Cancer Global Clinical Trials Review, H1, 2015

GlobalDataが出版した調査資料(GDHC2586CTIDB)・商品コード:GDHC2586CTIDB
・発行会社(調査会社):GlobalData
・発行日:2015年2月27日
・ページ数:247
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における腸癌(Intestinal Cancer) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 腸癌(Intestinal Cancer)
  - 当レポートの概要
・腸癌(Intestinal Cancer):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Intestinal Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H1, 2015″ provides data on the Intestinal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intestinal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intestinal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Intestinal Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Intestinal Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Intestinal Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Intestinal Cancer 25
Subjects Recruited Over a Period of Time 50
Clinical Trials by Sponsor Type 51
Prominent Sponsors 52
Top Companies Participating in Intestinal Cancer Therapeutics Clinical Trials 53
Prominent Drugs 54
Clinical Trial Profiles 55
Clinical Trial Overview of Top Companies 55
F. Hoffmann-La Roche Ltd. 55
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 55
Sanofi 73
Clinical Trial Overview of Sanofi 73
Pfizer Inc. 82
Clinical Trial Overview of Pfizer Inc. 82
Amgen Inc. 88
Clinical Trial Overview of Amgen Inc. 88
Novartis AG 93
Clinical Trial Overview of Novartis AG 93
Bristol-Myers Squibb Company 97
Clinical Trial Overview of Bristol-Myers Squibb Company 97
AstraZeneca PLC 101
Clinical Trial Overview of AstraZeneca PLC 101
E. Merck KG 105
Clinical Trial Overview of E. Merck KG 105
Otsuka Holdings Co., Ltd. 109
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 109
Bayer AG 112
Clinical Trial Overview of Bayer AG 112
Clinical Trial Overview of Top Institutes / Government 115
National Cancer Institute 115
Clinical Trial Overview of National Cancer Institute 115
Memorial Sloan Kettering Cancer Center 131
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 131
University of Texas M. D. Anderson Cancer Center 135
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 135
European Organization for Research and Treatment of Cancer 138
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 138
Sun Yat-sen University 141
Clinical Trial Overview of Sun Yat-sen University 141
FUDAN University 143
Clinical Trial Overview of FUDAN University 143
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group 145
Clinical Trial Overview of Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group 145
Cancer Research UK 147
Clinical Trial Overview of Cancer Research UK 147
City of Hope 149
Clinical Trial Overview of City of Hope 149
NCIC Clinical Trials Group 151
Clinical Trial Overview of NCIC Clinical Trials Group 151
Five Key Clinical Profiles 153
Appendix 244
Abbreviations 244
Definitions 244
Research Methodology 245
Secondary Research 245
About GlobalData 246
Contact Us 246
Disclaimer 246
Source 247

List of Tables
Intestinal Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7
Intestinal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Intestinal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Intestinal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Intestinal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Intestinal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Intestinal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Intestinal Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Intestinal Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Intestinal Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Intestinal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Intestinal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Intestinal Cancer Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Intestinal Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27
Intestinal Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 31
Intestinal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 50
Intestinal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 51
Intestinal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 52
Intestinal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 53
Intestinal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 54
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 55
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 73
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 82
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 88
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 93
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 97
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 101
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 105
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 109
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 112
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 115
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 131
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015* 135
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 138
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 141
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2015* 143
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group, 2015* 145
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK, 2015* 147
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope, 2015* 149
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2015* 151

List of Figures
Intestinal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Intestinal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Intestinal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Intestinal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Intestinal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Intestinal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Intestinal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Intestinal Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Intestinal Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Intestinal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Intestinal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Intestinal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Intestinal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 50
Intestinal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 51
Intestinal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 52
Intestinal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 53
Intestinal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 54
GlobalData Methodology 245

【レポートのキーワード】

腸癌(Intestinal Cancer)、治験、臨床試験、治験、治療薬

★調査レポート[腸癌(Intestinal Cancer):世界の治験レビュー(2015年上半期版)] (コード:GDHC2586CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[腸癌(Intestinal Cancer):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆